180 related articles for article (PubMed ID: 29156007)
1. Desmoplastic nodular medulloblastoma in young children: a management dilemma.
AbdelBaki MS; Boué DR; Finlay JL; Kieran MW
Neuro Oncol; 2018 Jul; 20(8):1026-1033. PubMed ID: 29156007
[TBL] [Abstract][Full Text] [Related]
2. Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221).
Lafay-Cousin L; Bouffet E; Strother D; Rudneva V; Hawkins C; Eberhart C; Horbinski C; Heier L; Souweidane M; Williams-Hughes C; Onar-Thomas A; Billups CA; Fouladi M; Northcott P; Robinson G; Gajjar A
J Clin Oncol; 2020 Jan; 38(3):223-231. PubMed ID: 31774708
[TBL] [Abstract][Full Text] [Related]
3. Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles.
Korshunov A; Sahm F; Okonechnikov K; Ryzhova M; Stichel D; Schrimpf D; Casalini B; Sievers P; Meyer J; Zheludkova O; Golanov A; Lichter P; Jones DTW; Pfister SM; Kool M; von Deimling A
Acta Neuropathol; 2019 Jun; 137(6):1003-1015. PubMed ID: 30826918
[TBL] [Abstract][Full Text] [Related]
4. Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia.
Yamasaki F; Takayasu T; Nosaka R; Kawaguchi H; Sugiyama K; Kobayashi M; Kurisu K
Childs Nerv Syst; 2016 Feb; 32(2):395-8. PubMed ID: 26231569
[TBL] [Abstract][Full Text] [Related]
5. Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma: a report from the children's oncology group.
Leary SE; Zhou T; Holmes E; Geyer JR; Miller DC
Cancer; 2011 Jul; 117(14):3262-7. PubMed ID: 21246528
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma in young children.
Rutkowski S; Cohen B; Finlay J; Luksch R; Ridola V; Valteau-Couanet D; Hara J; Garre ML; Grill J
Pediatr Blood Cancer; 2010 Apr; 54(4):635-7. PubMed ID: 20146217
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Analysis of the Demographics, Treatment, and Survival Outcomes of Patients with Desmoplastic Nodular Medulloblastoma Using the Surveillance, Epidemiology, and End Results (SEER) Database.
Gendreau JL; Gupta S; Giles TX; Stone CE; Abraham ME; Lindley JG
Cureus; 2020 Jul; 12(7):e9042. PubMed ID: 32782862
[TBL] [Abstract][Full Text] [Related]
8. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
9. Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy.
Pompe RS; von Bueren AO; Mynarek M; von Hoff K; Friedrich C; Kwiecien R; Treulieb W; Lindow C; Deinlein F; Fleischhack G; Kuehl J; Rutkowski S
Eur J Cancer; 2015 Nov; 51(17):2634-42. PubMed ID: 26346136
[TBL] [Abstract][Full Text] [Related]
10. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
[TBL] [Abstract][Full Text] [Related]
11. Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature.
Siegfried A; Bertozzi AI; Bourdeaut F; Sevely A; Loukh N; Grison C; Miquel C; Lafon D; Sevenet N; Pietsch T; Dufour C; Delisle MB
Clin Neuropathol; 2016; 35(3):106-13. PubMed ID: 26857864
[TBL] [Abstract][Full Text] [Related]
12. Childhood medulloblastoma: progress and future challenges.
Packer RJ
Brain Dev; 1999 Mar; 21(2):75-81. PubMed ID: 10206522
[TBL] [Abstract][Full Text] [Related]
13. Clinical management of medulloblastoma in adults.
Eisenstat DD
Expert Rev Anticancer Ther; 2004 Oct; 4(5):795-802. PubMed ID: 15485314
[TBL] [Abstract][Full Text] [Related]
14. Evidence in medulloblastomas.
Navajas A; Giralt J
Clin Transl Oncol; 2010 Apr; 12(4):271-7. PubMed ID: 20462836
[TBL] [Abstract][Full Text] [Related]
15. Risk-adapted chemotherapy in childhood medulloblastoma.
Varan A
Expert Rev Anticancer Ther; 2011 May; 11(5):771-80. PubMed ID: 21554052
[TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy in children with newly-diagnosed medulloblastoma.
Grill J; Dufour C; Kalifa C
Lancet Oncol; 2006 Oct; 7(10):787-9. PubMed ID: 17012036
[No Abstract] [Full Text] [Related]
19. Medulloblastoma: presentation, diagnosis and management.
Packer RJ; Finlay JL
Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma variants and survival at a children's hospital.
Craver R; Sandquist D; Nadell J; Velez M
Fetal Pediatr Pathol; 2011; 30(1):53-9. PubMed ID: 21204667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]